Seema A. Khan

Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate

N. Hansen, W. Gradishar, I. Helenowski, 2019, Clinical Cancer Research.